Also categorized in BoardMoves:
Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
x hide permanently

Catalyst Biosciences Announces Addition of Geoffrey Shiu Fei Ling, M.D. and Sharon Tetlow to Board of Directors

StreetInsider.com

SOUTH SAN FRANCISCO, Calif., Jan. 17, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company developing novel treatments for hemophilia and other rare bleeding disorders, today announced the appointment of Geoffrey Shiu Fei Ling, M.D. and Sharon Tetlow to the Company’s Board of Directors...

Mentions: Nasdaq Catalyst Catalyst Biosciences, Inc.